GREENLAND MINES LTD Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
GREENLAND MINES LTD (GRML) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 44.67 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-17
- GREENLAND MINES LTD antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 44.62M shares, a 270.93% increase year-over-year.
- GREENLAND MINES LTD antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 12.03M shares.
- GREENLAND MINES LTD antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.07M shares, a 57.84% decline from fiscal 2024.
- GREENLAND MINES LTD antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.03M shares, a 0.00% change from fiscal 2023.
- GREENLAND MINES LTD antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.03M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 44.67M shares 10-Q · filed 2026-08-17 | ||||
| 2026-03-31 | 44.62M shares 10-Q/A · filed 2026-08-14 | ||||
| 2025-12-31 | 5.07M shares 10-K/A · filed 2026-08-14 | ||||
| 2025-09-30 | 5.07M shares 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 12.03M shares 10-Q · filed 2026-08-17 | 11.32M shares 10-Q · filed 2025-08-18 | |||
| 2025-03-31 | 12.03M shares 10-Q/A · filed 2026-08-14 | ||||
| 2024-12-31 | 12.03M shares 10-K/A · filed 2026-08-14 | ||||
| 2024-09-30 | 12.03M shares 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | 12.03M shares 10-Q · filed 2025-08-18 | ||||
| 2023-12-31 | 12.03M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 12.03M shares 10-Q · filed 2024-11-19 | ||||
| 2023-06-30 | 12.03M shares 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |